HeartSciences Inc.
For the period ended Oct 31, 2025. Filed Dec 15, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Oct 31, 2025 · Filed Dec 15, 2025
HSCS$2.83+6.0%Stored close · as of Nov 6, 2026
Contents
Item 1. Condensed Unaudited Financial Statements
| Condensed Balance Sheets as of October 31, 2025 and April 30, 2025 | 1 | |
| Condensed Statements of Operations for the three and six months ended October 31, 2025 and 2024 | 2 | |
| Condensed Statements of Stockholders' Equity for the three and six months ended October 31, 2025 and 2024 | 3 | |
| Condensed Statements of Cash Flows for the six months ended October 31, 2025 and 2024 | 5 | |
| Notes to the Condensed Unaudited Financial Statements | 6 | |
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 22 |
|---|---|---|
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 27 |
| Item 4. | Controls and Procedures | 27 |
| PART II. | OTHER INFORMATION | 29 |
| Item 1. | Legal Proceedings | 29 |
| Item 1A. | Risk Factors | 29 |
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 29 |
| Item 3. | Defaults Upon Senior Securities | 29 |
| Item 4. | Mine Safety Disclosures | 29 |
| Item 5. | Other Information | 29 |
| Item 6. | Exhibits | 30 |
| Signatures | 34 |
i
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.